Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K38/00—Medicinal preparations containing peptides
  • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
  • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
  • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
  • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
  • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
  • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/0012—Galenical forms characterised by the site of application
  • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
  • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Public Health (AREA)
• Animal Behavior & Ethology (AREA)
• Epidemiology (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Biomedical Technology (AREA)
• Neurosurgery (AREA)
• Inorganic Chemistry (AREA)
• Neurology (AREA)
• Dermatology (AREA)
• Immunology (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Hospice & Palliative Care (AREA)
• Psychiatry (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Organic Chemistry (AREA)
• Medicinal Preparation (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
• Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
• Epoxy Resins (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Chemical Vapour Deposition (AREA)
• Epoxy Compounds (AREA)

Applications Claiming Priority (1)

Publications (1)

Family

ID=61300274

Family Applications (2)

Family Applications Before (1)

Country Status (21)

Families Citing this family (6)

Family Cites Families (187)

• 2017
  • 2017-08-09 JP JP2019508893A patent/JP7193448B2/ja active Active
  • 2017-08-09 US US16/328,582 patent/US12370233B2/en active Active
  • 2017-08-09 PT PT178456588T patent/PT3506921T/pt unknown
  • 2017-08-09 HU HUE17845658A patent/HUE062393T2/hu unknown
  • 2017-08-09 HU HUE23173177A patent/HUE071047T2/hu unknown
  • 2017-08-09 EP EP17845658.8A patent/EP3506921B1/en active Active
  • 2017-08-09 SI SI201731391T patent/SI3506921T1/sl unknown
  • 2017-08-09 PL PL17845658.8T patent/PL3506921T3/pl unknown
  • 2017-08-09 SM SM20230251T patent/SMT202300251T1/it unknown
  • 2017-08-09 MX MX2019002284A patent/MX2019002284A/es unknown
  • 2017-08-09 ES ES17845658T patent/ES2952044T3/es active Active
  • 2017-08-09 CA CA3035147A patent/CA3035147A1/en active Pending
  • 2017-08-09 FI FIEP17845658.8T patent/FI3506921T3/fi active
  • 2017-08-09 WO PCT/IL2017/050882 patent/WO2018042415A1/en not_active Ceased
  • 2017-08-09 LT LTEPPCT/IL2017/050882T patent/LT3506921T/lt unknown
  • 2017-08-09 SM SM20250136T patent/SMT202500136T1/it unknown
  • 2017-08-09 DK DK17845658.8T patent/DK3506921T3/da active
  • 2017-08-09 IL IL301455A patent/IL301455B2/en unknown
  • 2017-08-09 BR BR112019003594-0A patent/BR112019003594A2/pt unknown
  • 2017-08-09 EP EP23173177.9A patent/EP4252849B1/en active Active
  • 2017-08-09 AU AU2017319728A patent/AU2017319728B2/en active Active
  • 2017-08-09 HR HRP20230738TT patent/HRP20230738T1/hr unknown
  • 2017-08-09 PL PL23173177.9T patent/PL4252849T3/pl unknown
  • 2017-08-09 RS RS20250341A patent/RS66690B1/sr unknown
  • 2017-08-09 ES ES23173177T patent/ES3023741T3/es active Active
  • 2017-08-09 RS RS20230617A patent/RS64445B1/sr unknown
  • 2017-08-09 HR HRP20250396TT patent/HRP20250396T1/hr unknown
  • 2017-08-09 CN CN201780068092.9A patent/CN109982712A/zh active Pending
• 2019
  • 2019-02-19 IL IL264914A patent/IL264914B2/en unknown

Also Published As

Similar Documents